It has been reported that miR-34a can regulate tumor angiogenesis by directly inhibiting angiogenic functions of endothelial cells by downregulating several key proteins including E2F3, SIRT1 and CDK4 in HNSCC (21). The gene discussed is E2F3; the disease is neoplasm.